Crawford Fund Management’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.2M Sell
73,000
-153,700
-68% -$4.94M 0.42% 54
2025
Q4
$7.08M Sell
226,700
-21,300
-9% -$525K 0.93% 28
2025
Q3
$5.01M Sell
248,000
-18,000
-7% -$316K 0.8% 37
2025
Q2
$4.46M Buy
266,000
+48,500
+22% +$783K 0.83% 37
2025
Q1
$3.34M Buy
217,500
+65,500
+43% +$1.17M 0.8% 40
2024
Q4
$3.35M Sell
152,000
-4,500
-3% -$81.9K 0.58% 55
2024
Q3
$2.82M Buy
156,500
+38,500
+33% +$674K 0.6% 62
2024
Q2
$1.92M Sell
118,000
-121,000
-51% -$1.86M 0.48% 66
2024
Q1
$3.37M Sell
239,000
-170,400
-42% -$2.15M 0.81% 46
2023
Q4
$4.27M Buy
+409,400
New +$3.82M 0.85% 40

Other funds holding TEVA